5-hydroxydopamine has been researched along with Parkinson Disease in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (80.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mazzio, E; Soliman, KF | 1 |
| Andrew, R; Best, SA; Midgley, JM; Petty, RK; Watson, DG; Wenlong, H | 1 |
| Herlinger, E; Jellinger, K; Kienzl, E; Linert, L; Youdim, MB | 1 |
| Jameson, RF; Jellinger, K; Kienzl, E; Linert, W; Puchinger, L; Stachelberger, H | 1 |
| Jellinger, K; Kienzl, E; Linert, W; Stachelberger, H | 1 |
5 other study(ies) available for 5-hydroxydopamine and Parkinson Disease
| Article | Year |
|---|---|
Pyruvic acid cytoprotection against 1-methyl-4-phenylpyridinium, 6-hydroxydopamine and hydrogen peroxide toxicities in vitro.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Hydrogen Peroxide; Hydroxydopamines; Neuroblastoma; Neuroprotective Agents; Parkinson Disease; Pyruvic Acid; Tumor Cells, Cultured | 2003 |
The determination of hydroxydopamines and other trace amines in the urine of parkinsonian patients and normal controls.
Topics: Biogenic Monoamines; Dopamine; Gas Chromatography-Mass Spectrometry; Humans; Hydroxydopamines; Levodopa; Norepinephrine; Oxidopamine; Parkinson Disease; Tyramine | 1993 |
Chemical evidence for 6-hydroxydopamine to be an endogenous toxic factor in the pathogenesis of Parkinson's disease.
Topics: Dopamine; Electron Transport; Ferric Compounds; Ferritins; Hydroxydopamines; Hydroxyl Radical; In Vitro Techniques; Kinetics; Molecular Structure; Neurotoxins; Oxidation-Reduction; Oxidopamine; Oxygen; Parkinson Disease; Spectrophotometry; Spectrophotometry, Ultraviolet | 1995 |
The role of transition metals in the pathogenesis of Parkinson's disease.
Topics: Adrenergic Agents; Aged; Chromatography, High Pressure Liquid; Dopamine; Electron Probe Microanalysis; Humans; Hydroxydopamines; Iron; Lipid Peroxidation; Metals; Microscopy, Electron, Scanning; Microscopy, Fluorescence; Oxidopamine; Parkinson Disease; Substantia Nigra | 1995 |
Iron as catalyst for oxidative stress in the pathogenesis of Parkinson's disease?
Topics: Aged; Aged, 80 and over; Brain; Catalysis; Dopamine; Electron Probe Microanalysis; Humans; Hydroxydopamines; In Vitro Techniques; Iron; Kinetics; Lewy Bodies; Oxidative Stress; Oxidopamine; Parkinson Disease; Triazines | 1999 |